Around 26 companies, with a market capitalisation of over Rs 2,500 crore, reported atleast 25% year-on-year (YoY) fall in both revenue and profits in the last quarter, and a majority of them were part of the chemicals and pesticides sector.
A few smallcap stocks, whose weights have gone up, such as Glaxosmithkline Pharma, Fine Organic Industries, PTC Industries and Suven Pharmaceuticals, among others, are expected to see negligible inflows.
Suven Pharmaceuticals is a listed CDMO while Cohance Lifesciences is an unlisted company which was formed to create a new brand entity for three formerly Advent-acquired companies
US-based private equity firm Advent International is looking at making investments of $5-10 billion in India over the next five years, a media report said.
The ..
Suven Pharmaceuticals is a listed CDMO and Cohance Lifesciences is an unlisted API and CDMO platform. Both are part of private equity firm Advent International s India portfolio.